• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

16
1
1
1

COUNTRY

1

CATEGORIES

  • 13
  • 11
  • 11
  • 10
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

5
15
17
71

PUBLISHED

1
6
31
71

PRODUCT TYPE

59
12

Search "MultiCell Technologies Inc.-Therapeutic Competitors" returned 71 results.

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

Global Market Watch: Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,...

April 2015
FROM

Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report

Stem cell research and experimentation have been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature...

April 2015
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014’, provides an overview of the Hematopoietic Stem...

October 2014
FROM

MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review

MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2015
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015’, provides an overview of the Hematopoietic Stem...

May 2015
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014’, provides an overview of the...

April 2014
FROM

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

June 2015
FROM

Fatigue - Pipeline Review, H1 2015

Fatigue - Pipeline Review, H1 2015 Summary This, ‘Fatigue - Pipeline Review, H1 2015’, provides an overview of the Fatigue’s therapeutic pipeline. This report provides comprehensive information on...

January 2015
FROM

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

March 2015
FROM

Ischemic Stroke - Pipeline Review, H1 2015

Ischemic Stroke - Pipeline Review, H1 2015 Summary: This, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides...

March 2015
FROM

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014 Summary This, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014’, provides an overview of the Congestive Heart...

October 2014
FROM

Myocardial Infarction - Pipeline Review, H1 2015

Myocardial Infarction - Pipeline Review, H1 2015 Summary: This, ‘Myocardial Infarction - Pipeline Review, H1 2015’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This...

March 2015
FROM

Regenerative Medicine - Global Strategic Business Report

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World....

June 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the...

October 2014
FROM

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review,...

June 2015
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015’, provides an overview of the...

January 2015
FROM

Subcutaneous Biologics Market, 2015 - 2025

Amongst various efforts to ensure efficient drug delivery, subcutaneous administration has emerged as one of the most promising approaches to deliver viscous biologic drugs in a patient friendly format....

January 2015
FROM

Myocardial Infarction - Pipeline Review, H2 2014

Myocardial Infarction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2014’, provides an overview of the Myocardial Infarction’s therapeutic...

July 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2014’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

September 2014
FROM
Loading Indicator

Our Clients

Abbott Laboratories Ltd. Ford Motor Company Honeywell International, Inc. Nike, Inc. Deloitte LLP. IMAX Corporation